Ph: 207.396.6433 Fx: 207.396.6436
51 US Route 1 Suite H Scarborough, ME 04074
MetabolicLeader Logo

Metabolic Leader
We specialize in the diagnosis, treatment, and prevention of metabolic disorders of the endocrine system. Opened on November 15, 2010 by Dr. Stephan Babirak to provide the highest quality patient – focused healthcare in the southern Maine region.


We are now located at
51 US Route 1, Suite H Scarborough, ME 04074

Our Hours

Monday - Thursday
Office Hours:
8:00am – 4:00pm
Phone Hours:
9:00am – 4:00pm
Closed for lunch:
12:00 – 1:00pm
Closed on Friday

Healthy Food, Healthy You!

Eat healthy & get fit with these helpful tips.

APHERESIS Apheresis Video

View our video promoting a higher quality of life through Apheresis.

Are you at Risk for Diabetes?

To Buy Imuran Online Visit Our Pharmacy ↓

The History and Development of Imuran as a Medication

Imuran, the trade name for azathioprine, marks a significant milestone in medical history with its inception traced back to the late 1950s. Initially synthesized as a part of cancer research, its immunosuppressive properties were serendipitously discovered, signifying a pivotal moment in pharmaceutical development. The research led by Dr. Gertrude Elion and Dr. George Hitchings, whose endeavors in nucleic acids research would later earn them the Nobel Prize in Physiology or Medicine in 1988, laid the groundwork for this groundbreaking discovery.

Transitioning from its cancer research origins, Imuran's potential in abating the immune system's response was quickly recognized as a revolutionary advancement for organ transplantation. This turning point in its development steered the medical field toward a new horizon, vastly improving the outcomes of organ transplants by preventing the body's rejection of foreign tissues. The legacy of Imuran's development is a testament to the extraordinary outcomes that can emerge from research, even when they deviate unexpectedly from the original intentions.

How Imuran Revolutionized Transplant Medicine Forever

Imuran, clinically known as azathioprine, marked a pivotal turn in the field of organ transplantation, bringing about a revolution that surpassed the expectations of the medical community. Prior to its introduction, the success of transplant surgeries was severely limited by the body’s natural tendency to reject foreign tissues. Imuran’s ability to effectively suppress the immune system, thereby reducing this rejection, was a breakthrough that transformed the prospects of patients undergoing such procedures. It enabled longer graft survival rates and significantly improved the quality of life for recipients, shaping the landscape of transplant medicine into a realm of newfound possibilities.

The drug’s impact on transplant medicine cannot be overstated. By mitigating the immune system's aggressive response, Imuran allowed for a broader acceptance of transplant surgeries across the globe. This advancement not only enhanced the feasibility of performing these complex surgeries but also increased the survival rates and post-operative life expectancy of patients. The ripple effects of its introduction echoed throughout medical practices, leading to refined surgical techniques and post-operative care protocols. As a result, Imuran laid the foundation for the development of newer immunosuppressive agents, continually driving forward the evolution of transplant medicine.

The Science Behind Imuran: Understanding Its Mechanism

Imuran, chemically known as azathioprine, operates by inhibiting the body's immune response. At its core, azathioprine is a prodrug, meaning it only becomes active once metabolized by the body, converting into its active form, 6-mercaptopurine. This conversion is crucial as 6-mercaptopurine interferes with the synthesis of DNA and RNA, thereby suppressing the proliferation of immune cells, particularly T and B lymphocytes. This mechanism is fundamental in preventing the immune system from attacking transplanted organs, as well as in controlling autoimmune diseases by reducing the activity of the patient's immune system.

Understanding the delicate balance Imuran strikes in modulating the immune system is paramount. Its ability to reduce immunity without completely disabling it requires precise dosaging, as even slight deviations can significantly impact its efficacy and safety. By subtly adjusting the immune response, Imuran makes it possible for patients to undergo organ transplants and manage autoimmune conditions with reduced risk of rejection or flare-ups. However, this delicate balance also contributes to the profile of potential side effects, underscoring the importance of close medical supervision during treatment.

Navigating the Side Effects: the Less Discussed Chapter

Despite the significant benefits Imuran (azathioprine) offers, particularly in transplant medicine and auto-immune disorders, its administration is often shadowed by a range of side effects. These side effects vary in severity and frequency, affecting patients in different ways. Notably, some of the common issues include increased susceptibility to infections due to the suppression of the immune system, liver toxicity, and gastrointestinal symptoms. Additionally, there is a long-term risk of developing certain types of cancers due to chronic immunosuppression. These adverse effects necessitate careful monitoring and management strategies to mitigate risks while leveraging the therapeutic benefits of Imuran.

Healthcare professionals play a crucial role in identifying and managing the side effects associated with Imuran. By closely observing the patient’s condition and promptly addressing any adverse symptoms, the complications can be controlled. Moreover, patient education on recognizing early signs of side effects is imperative for timely intervention. Adjustments to dosage or switching to alternative medications may be considered in cases where side effects are severe or persistent. Thus, while Imuran represents a leap forward in managing complex conditions, navigating its side effects requires a careful and informed approach to ensure patient safety and therapeutic success.

Imuran Beyond Transplants: Expanding Therapeutic Uses

While Imuran (azathioprine) gained notable prominence in transplant medicine by preventing organ rejection, its therapeutic applications have broadened significantly over the years. Beyond its cornerstone role in transplant medicine, azathioprine has found its place in treating a variety of autoimmune diseases, such as rheumatoid arthritis, Crohn's disease, and ulcerative colitis. This expansion is mainly due to its ability to modulate the immune system, reducing inflammation and autoimmune activity in conditions beyond those directly related to organ transplants.

The versatility of Imuran in treating diverse autoimmune conditions underscores the evolving understanding of immune system-related diseases and the adaptability of this medication to meet a range of therapeutic needs. Continuous clinical studies further extend its usability, exploring new areas where its immunosuppressive properties can be beneficial. The drug's repurposing for diseases like lupus and certain dermatological conditions exemplifies the ongoing research efforts to maximize its potential benefits while managing its side effects, showcasing the dynamic nature of its therapeutic applications.

The Future of Imuran: Emerging Research and Developments

As the landscape of medicine continues to evolve, so too does the role of Imuran (azathioprine) in clinical treatments. Emerging research focuses on genetic factors influencing patient responses to the medication, aiming to personalize dosing strategies and minimize side effects. Novel formulations and delivery mechanisms are also under investigation to improve bioavailability and patient compliance. These advancements signify a future where Imuran's therapeutic potential is maximized across various conditions, bolstered by a deeper understanding of its pharmacodynamics and pharmacokinetics.

Concurrently, the scope of Imuran's application is broadening, with studies exploring its efficacy in new autoimmune disorders and chronic inflammatory conditions. Research into combination therapies offers promising strategies to enhance its effectiveness while reducing toxicity, opening avenues for its integration with newer immunomodulatory agents. Additionally, the development of biomarkers for monitoring treatment response and toxicity is a critical focus, aiming to optimize patient management and outcomes. This ongoing research and development underscore the enduring importance of Imuran in the therapeutic arsenal, even as it paves the way for innovative approaches to immunosuppression and inflammation control.